Subject: PDT
Network 1 Financial Securities, Inc. Introduces New Private Placement Offering for Test Enabling the Early Diagnosis of Autism
RED BANK, N.J., June 26, 2019 /PRNewswire-PRWeb/ -- Network 1 Financial Securities, Inc. Introduces New Private Placement Offering for Test Enabling the Early Diagnosis of Autism
Accredited Investors can Invest at NewAutismTest.com
RED BANK, N.J., June 25, 2019 ? Network 1 Financial Securities, Inc. today announced its newest 506© private placement offering1 for accredited investors, which can be found at NewAutismTest.com. Through this new offering, accredited investors have the opportunity to invest in a new test created by Autism Diagnostic Technologies, Inc. that has the ability to diagnose autism in infants.
According to the CDC, 1 out of every 592 children born in the United States today is diagnosed with autism, and yet currently there is no FDA approved technology for diagnosis.3 New technology developed at the University of Louisville has the potential to diagnose autism in children as young as 6 months, enabling earlier diagnosis and treatment. This new test uses artificial intelligence software and MRI scans to diagnose potential abnormalities in minutes.
"We are excited to offer accredited investors the opportunity to invest in this new patented technology at NewAutismTest.com," said Damon D. Testaverde, Chairman of Network 1 Financial Securities, Inc. "The test is a complete software solution that uses existing MRI scans to aid in the diagnosis of Autism Spectrum Disorder, and the capital raised for the company will be used to complete the software development, file a 510k with the FDA for approval, and fund other general corporate purposes."
Accredited investors can learn more about the new test and invest at NewAutismTest.com or contact Keith Testaverde at [email protected].
About Network 1 Financial Securities, Inc.
Network 1 Financial Securities, Inc. is an independent, full-service securities firm (Members FINRA|SIPC), positioned to move swiftly in response to changing investment climates, and ensures clients stay ahead of those changes with superior client service. Using state-of-the-art computer technology, the company provides important links to markets which gives clients access to company news and developing industry trends. For more information visit http://www.Network1.com or call 800-886-7007.
About Autism Diagnostic Technologies, Inc.
Autism Diagnostic Technologies, Inc. provides breakthrough technology for diagnosing brain disorders and diseases. We seek medical and/or technological partners to research additional uses for our technology and to develop new technologies.
###
1. Offerings made pursuant to Rule 506(c) of the Securities Act generally involve offering statements that are deemed to be private placements or private offering of securities; as such these offering statements are neither filed with nor qualified by the U.S. Securities & Exchange Commission. All investors must be accredited investors as defined by security regulations.
3. https://www.fda.gov/media/111099/download
SOURCE Network 1 Financial Securities, Inc.
These press releases may also interest you
|
News published on and distributed by:
